Open AccessTolerability of one hour 10mg/kg infliximab infusions in patients with inflammatory bowel disease
Author(s) -
Abdenour Babouri,
Anthony Buisson,
MarcAndré Bigard,
Laurent PeyrinBiroulet
Publication year - 2012
Publication title -
journal of crohn s and colitis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.277
H-Index - 80
eISSN - 1876-4479
pISSN - 1873-9946
DOI - 10.1016/j.crohns.2012.03.007
Subject(s) - tolerability , infliximab , medicine , inflammatory bowel disease , gastroenterology , crohn's disease , disease , adverse effect
In patients with inflammatory bowel disease (IBD) tolerating 2-h infusions of 5mg/kg infliximab scheduled maintenance therapy, the infusion time can be shortened to 1-h with good tolerability. The tolerability of one 1-hour 10 mg/kg infliximab infusion in patients with IBD is unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom